Airway anti-inflammatory effect can be maintained after salmeterol/fluticasone combination inhaler therapy is stepped down from medium to low dose for mild to moderate persistent asthmatics

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2015
INTERVENTION: To continue 1 year treatment with SFC250 or To receive step down treatment with SFC100 CONDITION: Bronchial asthma PRIMARY OUTCOME: The change of FeNO value after 1 year treatment INCLUSION CRITERIA: The asthmatics treated for at least 6 months with SFC 250 Diskus 2 puffs daily therapy, in whom the disease was well‐controlled or totally controlled,i.e., an ACT score of 20‐25 points, were eligible
Epistemonikos ID: c690f3a460d3494cac513b313c8c3ee32c726fb1
First added on: Aug 23, 2024